Provided by Tiger Trade Technology Pte. Ltd.

WUXI APPTEC

127.800
+2.7002.16%
Volume:819.14K
Turnover:105.54M
Market Cap:381.36B
PE:41.31
High:129.900
Open:127.900
Low:127.600
Close:125.100
52wk High:129.900
52wk Low:43.171
Shares:2.98B
HK Float Shares:510.48M
Volume Ratio:0.37
T/O Rate:0.16%
Dividend:1.51
Dividend Rate:1.18%
EPS(LYR):3.093
ROE:25.91%
ROA:11.28%
PB:4.74
PE(LYR):41.31
PS:7.66

Loading ...

BRIEF-Blackrock's Long Position In H-Shares Of WuXi AppTec Decreases To 4.51% On Feb 16 From 5.22%, HKEX Shows

Reuters
·
Feb 20

Morgan Stanley Reiterates Overweight on WUXI APPTEC, Raises Target Price to HK$143.5

Stock News
·
Feb 20

AH Share Premium Rankings as of February 17th

Stock News
·
Feb 17

AH Share Premium Rates and Deviations as of February 16

Stock News
·
Feb 16

JPMorgan Boosts Stake in WUXI APPTEC by Approximately 942,132 Shares at HK$116.09 Per Share

Stock News
·
Feb 13

CRO Stocks Lead Gains as Biopharma Investment and Cross-Border Deals Rebound

Stock News
·
Feb 10

Goldman Sachs: Mainland Healthcare Sector Returns to Hinge on Data and Earnings Visibility This Year, CDMO Firms Favored

Stock News
·
Feb 09

JPMorgan Reduces Stake in WUXI APPTEC by Approximately 798,119 Shares at HK$109.15 Each

Stock News
·
Feb 06

AH Share Premium Rankings as of February 5th

Stock News
·
Feb 05

WuXi AppTec (HKEX: 02359) Releases January 2026 Monthly Return on Movements in Securities

Bulletin Express
·
Feb 03

ZhTong A-H Statistics | January 27

Stock News
·
Jan 27

JPMorgan Reduces Stake in WUXI APPTEC (02359) by Approximately 2.52 Million Shares at HK$119.32 Per Share

Stock News
·
Jan 19

Zhitoing A-H Share Statistics | January 19

Stock News
·
Jan 19

Citi Maintains "Buy" Rating on WUXI APPTEC (02359) with Target Price of HK$142

Stock News
·
Jan 15

China Post Securities: AI Emerges as "Acceleration Engine" for New Drug Discovery, Recommends Focus on AI4S and AI+Pharmaceutical Sectors

Stock News
·
Jan 15

Global 16% Market Share and 80 Commercial Projects: Wuxi Apptec (02359) Adheres to Doing the Right Thing, with 167 Phase III and Commercialized Small Molecule Pipeline Projects

Stock News
·
Jan 15

Embracing Challenges for the Right Cause: WUXI APPTEC (02359) Supports 24 GLP-1 Drugs to Meet Urgent Clinical Needs

Stock News
·
Jan 15

Up to 447%! These Pharma Companies Double Profits: WuXi AppTec, Konruns Pharma...

Deep News
·
Jan 14

Citi Places WUXI APPTEC (02359) on 90-Day Positive Catalyst Watch with HK$142 Target

Stock News
·
Jan 14

CLSA: WUXI APPTEC (02359) Top Pick in China's Pharma CRO/CDMO Sector, Expected to Outperform Peers This Year

Stock News
·
Jan 14